FDA recall record

Curio Spice Co recall — FDA F-0215-2025

Product may be contaminated with mold.

Class IIclassification
F-0215-2025official record ID
Dec 4, 2024report date

Recall record at a glance

Official recordF-0215-2025
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmCurio Spice Co.
Report dateDec 4, 2024
Recall initiation dateOct 31, 2024
Quantity760 units
LocationWinchester, MA, United States

Official product description

Curio Spice Co. brand Grains of Paradise (Korerima) - Jar 1.25 oz net wt. UPC: 672975171032

Why the product was recalled

Product may be contaminated with mold.

Distribution information

AL, AK, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.